Anastasia Ripolin
- Pharmaceutical Science top 1%
- Biomedical Engineering
- Dermatology top 5%
- Biomaterials
- Public Health, Environmental and Occupational Health
- Co-authors
- Ryan F. DonnellyEneko LarrañetaJohanne BarryJames QuinnEva M. Vicente‐PérezAlejandro RodríguezA. A. PerminovaMikel Imízcoz
- Topics
- Advancements in Transdermal Drug Delivery (6 papers)Ocular Surface and Contact Lens (3 papers)Advanced Drug Delivery Systems (3 papers)
- Journals
- International Journal of PharmaceuticsACS Sustainable Chemistry & EngineeringAdvanced Healthcare Materials
- Partner nations
- United KingdomBrazilJordan
In The Last Decade
Anastasia Ripolin
8 papers receiving 493 citations
Peers
Comparison fields: 5 of 72
- Pharmaceutical Science 290
- Biomedical Engineering 168
- Dermatology 147
- Biomaterials 78
- Public Health, Environmental and Occupational Health 70
Countries citing papers authored by Anastasia Ripolin
This map shows the geographic impact of Anastasia Ripolin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anastasia Ripolin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anastasia Ripolin more than expected).
Fields of papers citing papers by Anastasia Ripolin
This network shows the impact of papers produced by Anastasia Ripolin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anastasia Ripolin. The network helps show where Anastasia Ripolin may publish in the future.
Co-authorship network of co-authors of Anastasia Ripolin
This figure shows the co-authorship network connecting the top 25 collaborators of Anastasia Ripolin. A scholar is included among the top collaborators of Anastasia Ripolin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anastasia Ripolin. Anastasia Ripolin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 17 | |
| 3 | 20 | |
| 4 | 46 | |
| 5 | 4 | |
| 6 | 69 | |
| 7 | 172 | |
| 8 | 163 |
About Anastasia Ripolin
Anastasia Ripolin is a scholar working on Pharmaceutical Science, Dermatology and Biochemistry, having authored 8 papers that have together received 496 indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (6 papers), Ocular Surface and Contact Lens (3 papers) and Advanced Drug Delivery Systems (3 papers). The work is most often cited by research in Pharmaceutical Science (290 citations), Dermatology (147 citations) and Biomaterials (78 citations). Anastasia Ripolin has collaborated with scholars based in United Kingdom, Brazil and Jordan. Frequent co-authors include Ryan F. Donnelly, Eneko Larrañeta, Johanne Barry, James Quinn, Eva M. Vicente‐Pérez, Alejandro Rodríguez, A. A. Perminova, Mikel Imízcoz, Juan Domínguez‐Robles and Nicola Irwin. Their work appears in journals such as International Journal of Pharmaceutics, ACS Sustainable Chemistry & Engineering and Advanced Healthcare Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.